We conclude that soluble transferrin receptor and high-fluorescence reticulocytes are not useful for distinguishing heterozygous beta-thalassemia from iron-deficiency anemia patients, although they provide interesting data concerning erythropoietic activity. The gene discussed is TFRC; the disease is Beta-thalassemia.